CIK 0001861657
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Canton Strategic Holdings, Inc.
Sign in to watch- Ticker
- CNTN
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842642541
- Phone
- +1 212-210-6006
- Business address
- 1460 BROADWAY, NEW YORK, NY, 10036
- Former names
- Tharimmune, Inc., Hillstream BioPharma Inc.
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 75,757 shares (gift)
- 4 Open-market buy Chief Executive Officer bought 500 shares at $0.78 ($390)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $0.69 ($688)
- 4 Open-market buy Chief Executive Officer bought 1 shares at $0.94 ($1)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $0.79 ($786)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $0.92 ($918)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $0.91 ($908)
- 4 Option exercise Chief Executive Officer acquired 240,526 shares (option exercise)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Conversion Chief Executive Officer acquired 276,289 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 260,674 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 384,325 shares (conversion)
- 3/A Insider 3/A
- 4 Open-market buy Director bought 25,000 shares at $4.00 ($100,000)
- 3 Insider Initial Statement of Ownership
Page 4 of 5 · 90 filings